Hydrogenics Reports Second Quarter 2013 Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Hydrogenics Reports Second Quarter 2013 Results

MISSISSAUGA, Ontario, Aug. 1, 2013 (GLOBE NEWSWIRE) -- Hydrogenics Corporation (Nasdaq: HYGS ) (TSX: HYG ) ("Hydrogenics" or "the Company"), a leading developer and manufacturer of hydrogen generation and hydrogen-based power modules, today reported second quarter 2013 financial results. Results are reported in US dollars and are prepared in accordance with International Financial Reporting Standards (IFRS).

"We continued to execute our growth strategy this quarter, with revenue up sharply year-over-year and solid gross margins," said Daryl Wilson, President and Chief Executive Officer. "Our target markets are expanding and we are dedicated to reaching profitability as soon as possible. While some lumpiness remains from quarter to quarter due to order timing, we are bidding on a significant number of energy storage projects, industrial applications, and fuel cell power modules and anticipate the second half of 2013 should see a strengthening of bookings and revenue. In the past few months, we have continued to showcase our unique hydrogen-based energy storage solutions in both North America and Europe, and we have continued working with CommScope to secure additional backup power orders. We are also pursuing fuel cell mobility applications and providing power modules as part of our long-term propulsion-related supply agreement. Overall, our balance sheet is strong and our focus on improved bottom line results unwavering."

Highlights for the Quarter Ended June 30, 2013 (compared to the quarter ended June 30, 2012, unless otherwise noted)

  • Revenue increased 18% to $9.8 million, reflecting higher bookings within Hydrogenics' Power Systems business unit partially offset by lower results from the OnSite Generation business unit.
     
  • During the quarter, Hydrogenics announced an order for a 1 Megawatt Proton Exchange Membrane ("PEM") energy storage system for the City of Hamburg, Germany. This "Power-to-Gas" facility will be run by E.ON, one of the world's largest integrated power and gas companies and an existing customer of Hydrogenics.
     
  • As previously disclosed, $6.9 million was raised by the Company from an underwritten share offering of 891,250 shares that closed in the second quarter of 2013. After underwriting fees and expenses the company realized $6.1 million in cash from the offering.
     
  • Hydrogenics secured $4.7 million of orders for renewable energy storage, industrial gas and power system applications during the quarter, resulting in an order backlog of $49.9 million as of June 30, 2013. Order backlog movement during the second quarter (in $ millions) was as follows:
  Mar. 31, 2013 Orders Orders Jun. 30, 2013
  Backlog Received Delivered Backlog
         
OnSite Generation $ 14.8 $ 3.4  $ 4.9 $ 13.3
Power Systems  40.2  1.3  4.9  36.6
Total $ 55.0 $ 4.7 $ 9.8 $ 49.9
  • Gross profit was $2.6 million, or 26.3% of revenue, a 8.5 percentage point increase year-over-year, primarily reflecting improved product mix of higher-margin Power Systems business.
     
  • Cash Operating Costs 1 were $3.8 million for the quarter, an increase of 11% compared to the second quarter of 2012, primarily resulting from net R&D expense, which increased 28% year-over-year in line with product development.
     
  • The Company's Adjusted EBITDA 2 loss increased by $0.9 million to $3.2 million for the reasons noted above as well as the impact of the incremental cost of compensation expense tied to the Company's stock price (restricted stock units, or "RSU," and deferred share units, or "DSU" plans), which increased by $1.5 million to $1.8 million from $0.3 million in the second quarter of 2012. These amounts are not reflected in Hydrogenics' definition of cash operating costs. 
     
  • The Company exited the second quarter with $16.0 million of cash and restricted cash, a $3.8 million increase over March 31, 2013, reflecting: (i) $6.1 million of net proceeds from the underwritten share issue; (ii) $0.7 million of proceeds from warrant and stock option exercises; and (iii) a $1.5 million decrease in non-cash working capital; partially offset by (iv) $2.4 million of cash used in operations; (v) $1.7 million repayment of operating borrowings and government contributions; and (vi) $0.3 million of negative foreign exchange resulting from the devaluation of the euro relative to the US dollar; and (vi) $0.3 million of other items.

Highlights for the Six months Ended June 30, 2013 (compared to the six months ended June 30, 2012, unless otherwise noted)

  • Revenue of $22.1 million, an increase of 58%, reflecting higher shipments within Hydrogenics' Power Systems group including  backup power orders for CommScope and initial revenue from the Company's previously-announced propulsion system contract.
     
  • Gross profit was $6.1 million, or 27.7% of revenues, a 11.4 percentage point increase over 2012, primarily reflecting improved product mix tied to the higher proportion of Power Systems revenue versus the prior-year period.
     
  • Cash operating costs 1 were $7.6 million, reflecting a $0.5 million increase in selling, general, and administrative costs associated with increased overall commercial activities.
     
  • Adjusted EBITDA 2 loss improved by $1.4 million to $4.0 million, primarily reflecting: (i) the improved margins noted above; partially offset by (ii) a $2.2 million increase in costs and fair value adjustments within the Company's DSU and RSU plans, indexed to Hydrogenics' share price; and (iii) the $0.6 million increase in cash operating costs noted above.

Notes

  1. Cash operating costs are defined as the sum of SG&A and R&D, less amortization and depreciation, and stock-based compensation expense inclusive of compensation costs indexed to our share price. This is a non-IFRS measure and may not be comparable to similar measures used by other companies. Management uses this measure as a rough estimate of the amount of fixed costs to operate the Corporation and believes this is a useful measure for investors for the same purpose.
     
  2. Adjusted EBITDA is defined as net loss excluding finance income, net, other losses, depreciation and amortization. Adjusted EBITDA is a non-IFRS measure and may not be comparable to similar measures used by other companies. Management uses adjusted EBITDA as a useful measure of cash flows.

Conference Call Details

Hydrogenics will hold a conference call at 10:00 a.m. EDT on August 1, 2013 to review the second quarter results. The telephone number for the conference call is (877) 307-1373 or, for international callers, (678) 224-7873. A live webcast of the call will also be available on the company's website, www.hydrogenics.com .

An archived copy of the conference call and webcast will be available on the company's website, www.hydrogenics.com , approximately six hours following the call. 

About Hydrogenics

Hydrogenics Corporation is a world leader in engineering and building the technologies required to enable the acceleration of a global power shift. Headquartered in Mississauga, Ontario, Hydrogenics provides hydrogen generation, energy storage and hydrogen power modules to its customers and partners around the world. Hydrogenics has manufacturing sites in  Germany, Belgium and Canada and service centres in Russia, Europe, the US and Canada.

Forward-looking Statements

This release contains forward-looking statements within the meaning of the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995, and under applicable Canadian securities law. These statements are based on management's current expectations and actual results may differ from these forward-looking statements due to numerous factors, including: our inability to increase our revenues or raise additional funding to continue operations, execute our business plan, or to grow our business; inability to address a slow return to economic growth, and its impact on our business, results of operations and consolidated financial condition; our limited operating history; inability to implement our business strategy;  fluctuations in our quarterly results; failure to maintain our customer base that generates the majority of our revenues; currency fluctuations; failure to maintain sufficient insurance coverage; changes in value of our goodwill; failure of a significant market to develop for our products; failure of hydrogen being readily available on a cost-effective basis; changes in government policies and regulations; failure of uniform codes and standards for hydrogen fuelled vehicles and related infrastructure to develop; liability for environmental damages resulting from our research, development or manufacturing operations; failure to compete with other developers and manufacturers of products in our industry; failure to compete with developers and manufacturers of traditional and alternative technologies; failure to develop partnerships with original equipment manufacturers, governments, systems integrators and other third parties; inability to obtain sufficient materials and components for our products from suppliers; failure to manage expansion of our operations; failure to manage foreign sales and operations; failure to recruit, train and retain key management personnel; inability to integrate acquisitions; failure to develop adequate manufacturing processes and capabilities; failure to complete the development of commercially viable products; failure to produce cost-competitive products; failure or delay in field testing of our products; failure to produce products free of defects or errors; inability to adapt to technological advances or new codes and standards; failure to protect our intellectual property; our involvement in intellectual property litigation; exposure to product liability claims;  failure to meet rules regarding passive foreign investment companies; actions of our significant and principal shareholders; dilution as a result of significant issuances of our common shares and preferred shares; inability of US investors to enforce US civil liability judgments against us; volatility of our common share price; and dilution as a result of the exercise of options. Readers should not place undue reliance on Hydrogenics' forward-looking statements. Investors are encouraged to review the section captioned "Risk Factors" in Hydrogenics' regulatory filings with the Canadian securities regulatory authorities and the US Securities and Exchange Commission for a more complete discussion of factors that could affect Hydrogenics' future performance. Furthermore, the forward-looking statements contained herein are made as of the date of this release, and Hydrogenics undertakes no obligations to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release, unless otherwise required by law. The forward-looking statements contained in this release are expressly qualified by this.

Hydrogenics Corporation
Consolidated Interim Balance Sheets
(in thousands of US dollars)
(unaudited)
     
  June 30 December 31
  2013 2012
Assets    
Current assets    
Cash and cash equivalents $ 12,345 $   13,020
Restricted cash 2,867 3,039
Trade and other receivables 3,808 5,615
Grants receivable -- 16
Inventories 12,282 12,213
Prepaid expenses 689 915
  31,991 34,818
Non-current assets    
Restricted cash 800 743
Property, plant and equipment 1,415 1,399
Intangible assets 90 107
Goodwill   4,972  5,021
  7,277 7,270
Total assets $ 39,268  $ 42,088
Liabilities    
Current liabilities    
Trade and other payables 11,647  11,946
Warranty provisions 1,338 1,252
Deferred revenue  6,498  11,597
Warrants 1,426 1,545
  20,909 26,340
Non-current liabilities    
Other non-current liabilities 2,273 2,384
Non-current warranty provisions 770 556
Non-current deferred revenue 7,941 8,576
Total liabilities 31,893 37,856
Equity    
Share capital 332,634  323,513
Contributed surplus 18,186  17,995
Accumulated other comprehensive loss  (1,101)  (999)
Deficit  (342,344)  (336,277)
Total equity 7,375  4,232
Total equity and liabilities   $ 39,268  $   42,088
 
 
 
Hydrogenics Corporation
Consolidated Interim Statements of Operations and Comprehensive Loss
(in thousands of US dollars, except share and per share amounts)
(unaudited)
         
  Three months ended  Six months ended 
  June 30 June 30
  2013 2012 2013 2012
Revenues $ 9,771  $  8,259 $ 22,083  $ 13,983
Cost of sales 7,205 6,787 15,975 11,706
Gross profit 2,566 1,472 6,108 2,277
         
Operating expenses        
Selling, general and administrative expenses 4,875 3,221 8,497 6,174
Research and product development expenses 1,080 843 2,018 1,992
  5,955 4,064 10,515 8,166
Loss from operations (3,389) (2,592)  (4,407)  (5,889)
         
Finance income (expenses)        
Interest income -- 6 7 12
Interest expense (94) (84) (186) (153)
Foreign currency gains 239 28 354 230
Foreign currency losses (87) (183) (299) (372)
Other finance gains (losses), net (1,185) (320)  (1,536)  (154)
Finance income (loss), net (1,127) (553) (1,660) (437)
         
Loss before income taxes (4,516) (3,145) (6,067) (6,326)
Income tax expense -- --     --  --
Net loss for the period (4,516) (3,145) (6,067) (6,326)
         
Other comprehensive income, net of tax        
Items that may be reclassified subsequently to net loss        
Exchange differences on translating foreign operations 196 (503) (102) (227)
Other comprehensive loss for the period, net of tax 196 (503) (102) (227)
         
Comprehensive loss for the period $ (4,320) $ (3,648) $ (6,169) $ (6,553)
         
Net loss per share        
Basic and diluted $ (0.53)  $ (0.42)  $ (0.74)  $ (0.90)
         
Weighted average number of common shares outstanding 8,542,637 7,462,012 8,194,937 7,033,830
         
 
 
 
Hydrogenics Corporation
Consolidated Interim Statements of Cash Flows
(in thousands of US dollars)
(unaudited)
         
  Three months ended Six months ended
  June 30 June 30
  2013 2012 2013 2012
Cash and cash equivalents provided by (used in):        
Operating activities        
Net loss for the period $ (4,516) $  (3,145) $ (6,067) $ (6,326)
Increase in restricted cash 340 (321) 115 (859)
Items not affecting cash:        
Amortization and depreciation 204 260 402 464
Other finance losses (gains), net 1,185 320 1,536 154
Unrealized foreign exchange (gains) losses (31) 165 80 (29)
Stock-based compensation 166 148 341 328
Portion of borrowings recorded as a reduction from research and development expenses -- (520) -- (520)
Accreted non-cash interest 82 106 171 127
Liabilities for compensation indexed to share price 1,811 264 2,212 381
Net change in other non-cash working capital (121) (1,320) (5,802) (515)
Cash used in operating activities (880) (4,043) (7,012) (6,795)
         
Investing activities        
Purchase of property, plant and equipment (220) (128) (409) (308)
Purchase of intangible assets -- (2) -- (4)
Cash used in investing activities (220) (130) (409) (312)
         
Financing activities        
Payment of post-retirement benefit liability (22) (23) (49)  (50)
Payment of repayable government contributions (250) (150) (250) (188)
Proceeds of operating borrowings -- 843 1,412 1,511
Repayment of operating borrowings (1,412) -- (1,412) --
Common shares issued, warrants and options exercised, net of issuance costs 6,811 4,851 7,234 4,851
Cash provided by financing activities 5,127 5,521 6,935 6,124
         
Effect of exchange rate fluctuations on cash and cash equivalents held 135 (312) (189) (114)
Increase (decrease) in cash and cash equivalents during the period 4,162 1,036 (675) (1,097)
Cash and cash equivalents - Beginning of period 8,183 5,652 13,020 7,785
Cash and cash equivalents - End of period $ 2,345 $  6,688 $ 12,345 $   6,688
         

Hydrogenics Contacts: Bob Motz, Chief Financial Officer Hydrogenics Corporation (905) 361-3660 Chris Witty Hydrogenics Investor Relations (646) 438-9385

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 1

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 2

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 3

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 7

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 3

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 2

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 2

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading
Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 2

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 2

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading

Top 5 Most Recently Viewed Articles

CoreWeave Partners with Nvidia for Advanced AI Development

Updated Category News Views 179

CoreWeave Enhances AI Capabilities CoreWeave, Inc. (NASDAQ: CRWV) has recently announced its plans to integrate advanced technologies from Nvidia Corporation (NASDAQ: NVDA) into its AI cloud platform. This move, which focuses on the incorporation of Nvidia's Rubin technology, aims to propel the capabilities of agentic AI, expand reasoning, and manage large-scale inference...

Continue Reading
Wall Street Adjusts Okta Earnings Forecast for Q3 Results

Updated Category News Views 145

Wall Street Analysts Revise Okta Earnings Predictions Okta, Inc. (NASDAQ: OKTA) is set to announce its earnings results for the third quarter shortly. Analysts are anticipating a significant development in the company's performance, with expectations centered around an increase in earnings per share. Quarterly Earnings Expectations Currently, experts predict that Okta...

Continue Reading
Bausch Health Enhances Financial Flexibility with $400 Million Loan

Updated Category News Views 208

Bausch Health Strengthens Financial Position Bausch Health Companies Inc. (NYSE: BHC), a prominent player in the pharmaceutical industry, has made a significant financial move by securing an amendment to its credit agreement. This amendment allows its subsidiary, Bausch + Lomb Corporation, to access an additional $400 million in term loans, boosting its financial...

Continue Reading
Unicoin Expands Digital Assets Reach with DiamondLake Acquisition

Updated Category News Views 200

Unicoin Expands Digital Asset Treasures through Strategic Acquisition Unicoin Inc., a leader in the digital currency landscape, is excited to share a transformative deal that underlines its commitment to growing the digital asset market. The company has finalized an agreement to acquire a 51% stake in Diamond Lake Minerals Inc. (OTC: DLMI), which is known for pioneering...

Continue Reading
Amneal's New FDA Approvals: Innovations in Pharmaceuticals and Care

Updated Category News Views 381

Amneal Pharmaceuticals Secures Key U.S. FDA Approvals Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) has successfully received approval from the U.S. Food and Drug Administration (FDA) for several important medications designed to improve patient care and meet the needs of various health conditions. This approval marks a significant milestone in the company’s journey to...

Continue Reading